🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
The purpose of this study is to evaluate whether maintenance antiretroviral...
Status
Completed
Location
Department of Infectious Diseases and Hospital Epidemiology, University Hospital of Basel
Start Date
2017-05-19
Trial ID
NCT03160105
Treatments Being Tested
Combination antiretroviral therapy (cART) HIV treatments are associated wit...
Status
Recruiting
Location
Mortimer Market Centre
Start Date
2022-08-17
Trial ID
NCT04892654
Treatments Being Tested
The purpose of this study was to evaluate the safety and immunotherapeutic ...
Status
Terminated
Location
Alabama CRS
Start Date
2019-08-13
Trial ID
NCT03787095
Treatments Being Tested
This is a single-arm, prospective, phase 2 clinical trial evaluating the im...
Status
Recruiting
Location
The First Affiliated Hospital of Soochow University
Start Date
2025-04-01
Trial ID
NCT07564453
The Antiretroviral Therapy as Long Acting Suppression (ATLAS) study is bein...
Status
Active Not Recruiting
Location
GSK Investigational Site
Start Date
2016-10-28
Trial ID
NCT02951052
This study is a pilot study to evaluate impact of Tripterygium Wilfordii Ho...
Status
Completed
Location
Peking Union Medical College Hospital
Start Date
2011-08
Trial ID
NCT02002286
Treatments Being Tested
This study will assess safety and feasibility of infusing genetically modif...
Status
Recruiting
Location
University of California, San Francisco
Start Date
2020-09-11
Trial ID
NCT04545762
Treatments Being Tested
MARCH is an international, multicentre trial planning to enroll 380 HIV-1 i...
Status
Completed
Location
Fundacion IDEAA
Start Date
2011-08
Trial ID
NCT01384682
Treatments Being Tested
This is an open label, randomised, two-arm switch study over 48 weeks in wh...
Status
Terminated
Location
Chelsea and Westminster Hospital NHS Foundation Trust
Start Date
2023-11-21
Trial ID
NCT05289986
Treatments Being Tested
This study is a 48-week, Phase IIIb, randomly assigned, open-label, active-...
Status
Completed
Location
GSK Investigational Site
Start Date
2014-04
Trial ID
NCT02105987
Treatments Being Tested